Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
national blog main
national top stories
new york blog main
new york top stories
pricing
7
×
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
7
×
san diego top stories
san francisco blog main
san francisco top stories
7
×
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
biotech
life sciences
bristol-myers squibb
donald trump
drug price
medicare
sanofi
democrats
drug prices
fda
lower
merck
negotiation
senate
What
bio
drug
pharmaceutical
roundup
american
away
based
best
continue
crash
debate
healthcare
house
industry
kind
lower
nash
people
plan
policy
politicians
pressure
price
prices
scalps
trump’s
u.s
advanced
airport
alnylam’s
anathema
annual
answer
apocalypse
approval
awaited
beds
bff
bringing
celgene
Language
unset
Current search:
pricing
×
" san francisco top stories "
×
" san diego blog main "
×
@xconomy.com
4 years ago
Pelosi, Dems Unveil Price Plan: Are 25 Drugs Enough for Negotiation?
@xconomy.com
4 years ago
After First Look at House Drug Plan, Stocks Rise Slightly
@xconomy.com
5 years ago
Bio Roundup: EASL Does It, Alnylam’s BFF, Gene Therapy Deals & More
@xconomy.com
5 years ago
Pharma CEOs to Senate: We Will Lower Drug Prices if Rebates Go Away
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Bio Roundup: Trump’s Scalps, Policy Pressure, NASH Crash & More
@xconomy.com
5 years ago
Notes from the JPM19 Vortex: Price Apocalypse, Celgene Fallout & More